Seastar Medical Submits Investigational Device Exemption (IDE) Application To FDA To Study A Novel Therapy To Reduce Hyperinflammation In Adult Acute Kidney Injury Patients

Press/Media

Period	9 Jan 2023

Media coverage

Title	Seastar Medical Submits Investigational Device Exemption (IDE) Application To FDA To Study A Novel Therapy To Reduce Hyperinflammation In Adult Acute Kidney Injury Patients
Media name/outlet	MENAFN -Press Releases (English)
Country/Territory	Jordan
Date	9/01/23
URL	metabase.moreover.com/noarticleurl?type=psh&lni=6838-YBG1-JBR8-B0R5-00000-00
Persons	Kevin Chung